
### [NCIT:C95984](http://purl.obolibrary.org/obo/NCIT_C95984)
**Label:** Ampulla of Vater Neuroendocrine Carcinoma

**Subclasses:** [NCIT:C6655](http://purl.obolibrary.org/obo/NCIT_C6655) (Ampulla of Vater Small Cell Neuroendocrine Carcinoma), [NCIT:C95985](http://purl.obolibrary.org/obo/NCIT_C95985) (Ampulla of Vater Large Cell Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 54.16%
- [NCIT:C28079](http://purl.obolibrary.org/obo/NCIT_C28079) (Grade 3) 51.85%
- [NCIT:C14158](http://purl.obolibrary.org/obo/NCIT_C14158) (High Grade) 51.85%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C14161](http://purl.obolibrary.org/obo/NCIT_C14161) (Low Grade))) 51.85%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 37.21%


